Antibody Drug Conjugates: A Leap Ahead in Cancer Treatment
Abstract
Monoclonal antibody (MAb) based targeted therapies have achieved appreciable success in various branches of drug therapeutics, predominantly when used along with cytotoxic drugs. These immunological therapies based on antibody-drug conjugates (ADCs) have been recently encouraged by the US Food and Drug Administration to treat Solid tumours, Melanoma, Breast Cancer and Hodgkin’s lymphoma. Antibody drug conjugates (ADCs) are an important...
Paper Details
Title
Antibody Drug Conjugates: A Leap Ahead in Cancer Treatment
Published Date
May 15, 2014
Volume
4
Issue
3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History